James Mandell, Director at bluebird bio, Inc. (BLUE), sold 1,933 shares at $150.06 ($291K) on 2018-09-10, disclosed to the SEC on 2018-09-12.
Open-market sale of $291k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.06 | 432 | $65K | 22.2% |
| 2 | $150.06 | 432 | $65K | 22.2% |
| 3 | $151.22 | 501 | $76K | 26.0% |
| 4 | $151.22 | 501 | $76K | 26.0% |
| 5 | $152.00 | 67 | $10K | 3.5% |
| Total | $150.73 avg | 1,933 |
| $291K |
| 100% |
| Filing → |
| BLUE | SELL | 2017-02-16 | $952K | — | Filing → |
| BLUE | SELL | 2017-02-02 | $600K | — | Filing → |
| BLUE | SELL | 2017-01-31 | $351K | — | Filing → |